These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 30498759

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The shades of anti-Jo1 positive antisynthetase syndrome in a Hungarian cohort].
    Szabó K, Nagy-Vincze M, Bodoki L, Hodosi K, Dankó K, Griger Z.
    Orv Hetil; 2016 Apr 10; 157(15):575-83. PubMed ID: 27039996
    [Abstract] [Full Text] [Related]

  • 3. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
    Cavagna L, Nuño L, Scirè CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castañeda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airò P, Cavazzana I, Martínez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, González-Gay MA, AENEAS (American and European NEtwork of Antisynthetase Syndrome) Collaborative Group.
    Clin Rev Allergy Immunol; 2017 Feb 10; 52(1):71-80. PubMed ID: 26782036
    [Abstract] [Full Text] [Related]

  • 4. Myositis-related interstitial lung disease and antisynthetase syndrome.
    Solomon J, Swigris JJ, Brown KK.
    J Bras Pneumol; 2011 Feb 10; 37(1):100-9. PubMed ID: 21390438
    [Abstract] [Full Text] [Related]

  • 5. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.
    Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelepis GE.
    Clin Rheumatol; 2007 Jan 10; 26(1):108-11. PubMed ID: 16328094
    [Abstract] [Full Text] [Related]

  • 6. Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
    Yang H, Chen Q, Sun C, Jin Q, Zhang L, Liu Q, Peng Q, Wang G, Lu X.
    Respir Res; 2024 May 29; 25(1):222. PubMed ID: 38811943
    [Abstract] [Full Text] [Related]

  • 7. Clinical manifestations and treatment of antisynthetase syndrome.
    Marco JL, Collins BF.
    Best Pract Res Clin Rheumatol; 2020 Aug 29; 34(4):101503. PubMed ID: 32284267
    [Abstract] [Full Text] [Related]

  • 8. Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases.
    Phuong TNT, Ngoc LNT, Rönnelid J, Padyukov L, Lundberg IE.
    Int J Rheum Dis; 2021 May 29; 24(5):663-670. PubMed ID: 33788398
    [Abstract] [Full Text] [Related]

  • 9. Clinical, Serological, and Genetic Characteristics of a Hungarian Myositis-Scleroderma Overlap Cohort.
    Szabó K, Bodoki L, Nagy-Vincze M, Béldi T, Vincze A, Zilahi E, Varga J, Szűcs G, Dankó K, Griger Z.
    Biomed Res Int; 2022 May 29; 2022():6251232. PubMed ID: 35547355
    [Abstract] [Full Text] [Related]

  • 10. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
    Martins P, Dourado E, Melo AT, Samões B, Sousa M, Freitas R, Lourenço MH, Fernandes B, Costa E, Parente H, Martins F, Fonseca JE, Cordeiro I, Romão VC, Khmelinskii N, Campanilho-Marques R.
    ARP Rheumatol; 2022 Nov 01; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
    [Abstract] [Full Text] [Related]

  • 11. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome.
    Marie I, Josse S, Hatron PY, Dominique S, Hachulla E, Janvresse A, Cherin P, Mouthon L, Vittecoq O, Menard JF, Jouen F.
    Arthritis Care Res (Hoboken); 2013 May 01; 65(5):800-8. PubMed ID: 23203765
    [Abstract] [Full Text] [Related]

  • 12. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 13. Antisynthetase syndrome presenting as interstitial lung disease: a case report.
    Badshah A, Haider I, Pervez S, Humayun M.
    J Med Case Rep; 2019 Aug 04; 13(1):241. PubMed ID: 31376837
    [Abstract] [Full Text] [Related]

  • 14. Anti-Jo-1 myositis and the antiphospholipid syndrome showing right ventricular thrombus: a novel overlap syndrome with atypical presentation.
    Wang CH, Wang NC, Lin TY, Chen CH.
    Mod Rheumatol; 2014 Sep 04; 24(5):865-8. PubMed ID: 24517557
    [Abstract] [Full Text] [Related]

  • 15. Antisynthetase syndrome.
    Katzap E, Barilla-LaBarca ML, Marder G.
    Curr Rheumatol Rep; 2011 Jun 04; 13(3):175-81. PubMed ID: 21455765
    [Abstract] [Full Text] [Related]

  • 16. Dermatomyositis sine myositis and antisynthetase syndrome.
    Climent-Albaladejo A, Saiz-Cuenca E, Rosique-Roman J, Caballero-Rodriguez J, Galvez-Munoz J.
    Joint Bone Spine; 2002 Jan 04; 69(1):72-5. PubMed ID: 11858361
    [Abstract] [Full Text] [Related]

  • 17. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW, Childhood Myositis Heterogeneity Collaborative Study Group.
    Medicine (Baltimore); 2013 Jul 04; 92(4):223-243. PubMed ID: 23877355
    [Abstract] [Full Text] [Related]

  • 18. ["Mechanic's hands" during antisynthetase syndrome: a marker of systemic involvement?].
    Nahas O, Haddad F, Maalouly G.
    Ann Dermatol Venereol; 2015 Mar 04; 142(3):189-92. PubMed ID: 25620556
    [Abstract] [Full Text] [Related]

  • 19. Antisynthetase Syndrome and Autoantibodies: A Literature Review and Report of 4 Cases.
    Marin FL, Sampaio HP.
    Am J Case Rep; 2019 Jul 25; 20():1094-1103. PubMed ID: 31344020
    [Abstract] [Full Text] [Related]

  • 20. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
    Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, Costedoat-Chalumeau N, Allenbach Y, Hervier B, Dubourg O, Maisonobe T, Charuel JL, Behin A, Herson S, Amoura Z, Grenier P, Benveniste O.
    J Rheumatol; 2012 Sep 25; 39(9):1835-9. PubMed ID: 22859355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.